Sub menu

 
 

MEROPENEM-AFT (AFT Pharmaceuticals Pty Ltd)

Product name
MEROPENEM-AFT
Sponsor
AFT Pharmaceuticals Pty Ltd
Date registered
Evaluation commenced
Decision date
Approval time
126 (255 working days)
Active ingredients
meropenem trihydrate
Registration type
New generic medicine
Indication

Meropenem is indicated for treatment of the following infections, in adults and children (aged 3 months and over), when the causative organisms are known or suspected to be resistant to commonly used antibiotics:

  • • Community acquired lower respiratory tract infection
  • • Hospital acquired lower respiratory tract infection
  • • Complicated urinary tract infection
  • • Febrile neutropenia
  • • Intra-abdominal and gynaecological (poly microbial) infections
  • • Complicated skin and skin structure infections
  • • Meningitis
  • • Septicaemia

    • Help us improve the Therapeutic Goods Administration site